Product catalog
Browse 90 active ingredients, finished dosage forms and development programs, made at our own facilities or sourced through our partner network.
90 of 90 products
GLP-1 & GIP peptides · 5
ProductTherapeutic areaBusiness modelRegulatory status
- LiraglutideGLP-1API + FDF CMO/SupplyUS DMFNDC
- OrforgliproninvestigationalOwn facilityGLP-1API + FDF CMO/SupplyNDC
- Retaglutide(Retatrutide)investigationalOwn facilityRetatrutideGLP-1API + FDF CMO/SupplyUS DMFNDC
- SemaglutideOwn facilityGLP-1API + FDF CMO/SupplyUS DMFNDC
- TirzepatideOwn facilityGLP-1API + FDF CMO/SupplyUS DMFNDC
Oligonucleotides · 11
ProductTherapeutic areaBusiness modelRegulatory status
- BepirovirseninvestigationalOwn facilityOligonucleotideOwn facility supply
- InclisiranOwn facilityOligonucleotide · Heart/Blood-healthCDMOGMPDMF
- NedosiranOwn facilityOligonucleotideOwn facility supply
- NusinersenOwn facilityOligonucleotideCDMO
- OlezarsenOwn facilityOligonucleotideOwn facility supply
- PegcetacoplanOligonucleotideCDMO
- SalanerseninvestigationalOwn facilityOligonucleotideOwn facility supply
- SiRNAOligonucleotideCDMO（siRNA+ASO）FDA
- TofersenOwn facilityOligonucleotideOwn facility supply
- VolanesorsenOwn facilityOligonucleotideOwn facility supply
- VutrisiranOwn facilityOligonucleotideOwn facility supply
Anti-aging · 5
ProductTherapeutic areaBusiness modelRegulatory status
- DDVFOwn facility3,4-DivanillyltetrahydrofuranCAS 34730-78-4Anti-ageOwn facility supply
- FAD+Own facilityCAS 146-14-5Anti-ageOwn facility supply
- L-CitrullineOwn facilityCAS 372-75-8Anti-ageOwn facility supply
- NAD+Own facilityAnti-ageInjectable pharma grade supplyDMF on-goingNDC
- NMNOwn facilityCAS 1094-61-7Anti-ageOwn facility supply
Bio-Synergy · 3
ProductTherapeutic areaBusiness modelRegulatory status
ADC & mAb (license-out) · 7
ProductTherapeutic areaBusiness modelRegulatory status
- Adebrelimab (PD-L1)PD-L1ADC/mAbLicense-outNMPA approval
- BevacizumabADC/mAb · mAbLicense-outNMPA approval
- Camrelizumab (PD-1)PD-1ADC/mAbLicense-outNMPA approval
- RamucirumabADC/mAb · mAbLicense-outNMPA approval
- Recaticimab (PCSK9)PCSK9ADC/mAbLicense-outNMPA approval
- Trastuzumab Rezetecan (HER2 ADC)investigationalHER2 ADCADC/mAbLicense-out
- VunakizumabADC/mAbLicense-out
Animal health · 6
ProductTherapeutic areaBusiness modelRegulatory status
- AfoxolanerAnimal-healthCDMO+API + device supplyVMF
- Atipamezole HclAnimal-healthCDMO+API + device supplyVMF
- Cefovecin SodiumAnimal-healthCDMO+API + device supplyVMF
- FirocoxibAnimal-healthCDMO+API + device supplyVMF
- FluralanerAnimal-healthCDMO+API + device supplyVMF
- OclacitinibAnimal-healthCDMO+API + device supplyVMF
Antibiotics · 8
ProductTherapeutic areaBusiness modelRegulatory status
- Human Insulin/Insulin GlargineAntibioticsGMP+DMF+Tech
- LymecyclineAntibioticsAPI supply
- Meropenam CarbonateAntibioticsAPI supplyGMPDMF
- Minocycline HclAntibioticsAPI supplyNMPA approval
- Omadacycline HclAntibioticsCDMO + API supplyNMPA approval
- Sarecycline HclAntibioticsCDMO + API supplyLocal GMPGMP
- Tazobactam SodiumAntibioticsAPI supplyLocal GMPGMP
- Tigecycline HclAntibioticsGMP+DMF readyGMPDMF
Antivirals · 4
ProductTherapeutic areaBusiness modelRegulatory status
Cardiovascular & hematology · 5
ProductTherapeutic areaBusiness modelRegulatory status
Dermatology & antifungals · 5
ProductTherapeutic areaBusiness modelRegulatory status
Hepatology · 1
ProductTherapeutic areaBusiness modelRegulatory status
Insulins · 4
ProductTherapeutic areaBusiness modelRegulatory status
Monoclonal antibodies · 3
ProductTherapeutic areaBusiness modelRegulatory status
Neurology (migraine) · 3
ProductTherapeutic areaBusiness modelRegulatory status
Oncology · 8
ProductTherapeutic areaBusiness modelRegulatory status
- CarfilzomibOncologyAPI supplyLocal GMPGMP
- Doxorubicin/EpirubicinOncologyAPI supplyEU GMPGMP
- Eribulin MesylateOncologyAPI supplyLocal GMPGMP
- FulvestrantOncologyAPI supplyFDADMF
- MitoxantroneOncologyAPI supplyLocal GMPGMP
- RelugolixOncologyAPI supplyLocal GMPGMP
- VincristineOncologyAPI supplyCOFPRISDMF
- VinorelbineOncologyAPI supplyCOFPRISDMF
Respiratory · 4
ProductTherapeutic areaBusiness modelRegulatory status
Surgery · 5
ProductTherapeutic areaBusiness modelRegulatory status
Women's health · 3
ProductTherapeutic areaBusiness modelRegulatory status